Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 May;26(5):528-538.
doi: 10.1111/acem.13709. Epub 2019 Mar 4.

Do High-sensitivity Troponin and Natriuretic Peptide Predict Death or Serious Cardiac Outcomes After Syncope?

Carol L Clark  1 , Thomas A Gibson  2 , Robert E Weiss  2 , Annick N Yagapen  3 , Susan E Malveau  3 , David H Adler  4 , Aveh Bastani  5 , Christopher W Baugh  6 , Jeffrey M Caterino  7 , Deborah B Diercks  8 , Judd E Hollander  9 , Bret A Nicks  10 , Daniel K Nishijima  11 , Manish N Shah  12 , Kirk A Stiffler  13 , Alan B Storrow  14 , Scott T Wilber  13 , Benjamin C Sun  3
Affiliations
Observational Study

Do High-sensitivity Troponin and Natriuretic Peptide Predict Death or Serious Cardiac Outcomes After Syncope?

Carol L Clark et al. Acad Emerg Med. 2019 May.

Abstract

Objectives: An estimated 1.2 million annual emergency department (ED) visits for syncope/near syncope occur in the United States. Cardiac biomarkers are frequently obtained during the ED evaluation, but the prognostic value of index high-sensitivity troponin (hscTnT) and natriuretic peptide (NT-proBNP) are unclear. The objective of this study was to determine if hscTnT and NT-proBNP drawn in the ED are independently associated with 30-day death/serious cardiac outcomes in adult patients presenting with syncope.

Methods: A prespecified secondary analysis of a prospective, observational trial enrolling participants ≥ age 60 presenting with syncope, at 11 United States hospitals, was conducted between April 2013 and September 2016. Exclusions included seizure, stroke, transient ischemic attack, trauma, intoxication, hypoglycemia, persistent confusion, mechanical/electrical invention, prior enrollment, or predicted poor follow-up. Within 3 hours of consent, hscTnT and NT-proBNP were collected and later analyzed centrally using Roche Elecsys Gen 5 STAT and 2010 Cobas, respectively. Primary outcome was combined 30-day all-cause mortality and serious cardiac events. Adjusting for illness severity, using multivariate logistic regression analysis, variations between primary outcome and biomarkers were estimated, adjusting absolute risk associated with ranges of biomarkers using Bayesian Markov Chain Monte Carlo methods.

Results: The cohort included 3,392 patients; 367 (10.8%) experienced the primary outcome. Adjusted absolute risk for the primary outcome increased with hscTnT and NT-proBNP levels. HscTnT levels ≤ 5 ng/L were associated with a 4% (95% confidence interval [CI] = 3%-5%) outcome risk, and hscTnT > 50 ng/L, a 29% (95% CI = 26%-33%) risk. NT-proBNP levels ≤ 125 ng/L were associated with a 4% (95% CI = 4%-5%) risk, and NT-proBNP > 2,000 ng/L a 29% (95% CI = 25%-32%) risk. Likelihood ratios and predictive values demonstrated similar results. Sensitivity analyses excluding ED index serious outcomes demonstrated similar findings.

Conclusions: hscTnT and NT-proBNP are independent predictors of 30-day death and serious outcomes in older ED patients presenting with syncope.

Trial registration: ClinicalTrials.gov NCT01802398.

PubMed Disclaimer

Figures

Appendix Figure 1.
Appendix Figure 1.
Event Rate vs Biomarker Levels
Appendix Figure 2.
Appendix Figure 2.
Event Rate vs log of Biomarker Levels
Figure 1.
Figure 1.
Study Cohort, Central Figure
See this image and copyright information in PMC

References

    1. Probst MA, Kanzaria HK, Gbedemah M, Richardson LD, Sun BC. National trends in resource utilization associated with ED visits for syncope. Am J Emerg Med. April 24 2015. - PMC - PubMed
    1. Sun BC, Emond JA, Camargo CA. Direct medical costs of syncope-related hospitalizations in the United States. The American Journal of Cardiology 2005;95(5):668–71. - PubMed
    1. Costantino G, Casazza G, Reed M, et al. Syncope Risk Stratification Tools vs Clinical Judgment: An Individual Patient Data Meta-analysis. The American Journal of Medicine 2014;127(11). - PubMed
    1. Serrano LA, Hess EP, Bellolio MF, et al. Accuracy and Quality of Clinical Decision Rules for Syncope in the Emergency Department: A Systematic Review and Meta-analysis. Annals of Emergency Medicine 2010;56(4). - PMC - PubMed
    1. Defilippi CR, Lemos JAD, Christenson RH, et al. Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults. Jama 2010;304(22):2494. - PMC - PubMed

Publication types

Associated data